thiotepa and Skin Diseases
thiotepa has been researched along with Skin Diseases in 5 studies
Thiotepa: A very toxic alkylating antineoplastic agent also used as an insect sterilant. It causes skin, gastrointestinal, CNS, and bone marrow damage. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), thiotepa may reasonably be anticipated to be a carcinogen (Merck Index, 11th ed).
Skin Diseases: Diseases involving the DERMIS or EPIDERMIS.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Mitomycin C 40 mg in 40 ml water was administered intravesically every week for 8 consecutive weeks to 60 patients with superficial bladder cancer." | 7.67 | Mitomycin C intravesical therapy in noninvasive bladder cancer after failure on thiotepa. ( Block, NL; Brannen, G; Cummings, KB; Flanagan, M; Issell, BF; Levin, EA; Prout, GR; Soloway, MS; Summers, JL; Veenema, R, 1984) |
"High-dose thiotepa, a polyfunctional alkylating agent used in the treatment of solid tumors in children and adults, has been reported to cause a variety of reactions in the skin, including erythema, blistering, and hyperpigmentation." | 3.74 | Cutaneous effects of thiotepa in pediatric patients receiving high-dose chemotherapy with autologous stem cell transplantation. ( Bayliss, SJ; Hayashi, RJ; Lloyd, BM; Rosman, IS, 2008) |
"Mitomycin C 40 mg in 40 ml water was administered intravesically every week for 8 consecutive weeks to 60 patients with superficial bladder cancer." | 3.67 | Mitomycin C intravesical therapy in noninvasive bladder cancer after failure on thiotepa. ( Block, NL; Brannen, G; Cummings, KB; Flanagan, M; Issell, BF; Levin, EA; Prout, GR; Soloway, MS; Summers, JL; Veenema, R, 1984) |
"Radiation pneumonitis was observed in 5 patients (7%), 4 of whom had undergone high-dose chemotherapy (P = 0." | 2.68 | The toxicity of radiotherapy following high-dose chemotherapy with peripheral blood stem cell support in high-risk breast cancer: a preliminary analysis. ( Baars, JW; Beijnen, JH; Borger, JH; Richel, DJ; Rodenhuis, S; Rutgers, EJ; Schaake-Koning, CC; Schornagel, JH; van der Wall, E; van Zandwijk, N, 1996) |
Research
Studies (5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
KENIS, Y | 2 |
VAN DER MEIREN, L | 2 |
Rosman, IS | 1 |
Lloyd, BM | 1 |
Hayashi, RJ | 1 |
Bayliss, SJ | 1 |
Issell, BF | 1 |
Prout, GR | 1 |
Soloway, MS | 1 |
Cummings, KB | 1 |
Brannen, G | 1 |
Veenema, R | 1 |
Flanagan, M | 1 |
Block, NL | 1 |
Summers, JL | 1 |
Levin, EA | 1 |
van der Wall, E | 1 |
Schaake-Koning, CC | 1 |
van Zandwijk, N | 1 |
Baars, JW | 1 |
Schornagel, JH | 1 |
Richel, DJ | 1 |
Rutgers, EJ | 1 |
Borger, JH | 1 |
Beijnen, JH | 1 |
Rodenhuis, S | 1 |
Greenspan, EM | 1 |
Jaffrey, I | 1 |
Bruckner, H | 1 |
Trials
1 trial available for thiotepa and Skin Diseases
Article | Year |
---|---|
The toxicity of radiotherapy following high-dose chemotherapy with peripheral blood stem cell support in high-risk breast cancer: a preliminary analysis.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carboplatin | 1996 |
Other Studies
4 other studies available for thiotepa and Skin Diseases
Article | Year |
---|---|
[Poikilodermic state; Hodgkin's disease of skin and ganglia, treatment by triethylenethiophosphoramide].
Topics: Antineoplastic Agents; Ganglia; Hodgkin Disease; Humans; Parapsoriasis; Skin; Skin Diseases; Thiotep | 1956 |
[Poikilodermic state; Hodgkin's disease of skin and ganglia, treatment by triethylenethiophosphoramide].
Topics: Antineoplastic Agents; Ganglia; Hodgkin Disease; Humans; Parapsoriasis; Skin; Skin Diseases; Thiotep | 1956 |
[Poikilodermic state; Hodgkin's disease of skin and ganglia, treatment by triethylenethiophosphoramide].
Topics: Antineoplastic Agents; Ganglia; Hodgkin Disease; Humans; Parapsoriasis; Skin; Skin Diseases; Thiotep | 1956 |
[Poikilodermic state; Hodgkin's disease of skin and ganglia, treatment by triethylenethiophosphoramide].
Topics: Antineoplastic Agents; Ganglia; Hodgkin Disease; Humans; Parapsoriasis; Skin; Skin Diseases; Thiotep | 1956 |
Cutaneous effects of thiotepa in pediatric patients receiving high-dose chemotherapy with autologous stem cell transplantation.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclopho | 2008 |
Mitomycin C intravesical therapy in noninvasive bladder cancer after failure on thiotepa.
Topics: Adult; Aged; Drug Evaluation; Humans; Inflammation; Middle Aged; Mitomycin; Mitomycins; Skin Disease | 1984 |
Thiotepa, cutaneous reactions, and efficacy.
Topics: Female; Humans; Methotrexate; Ovarian Neoplasms; Skin Diseases; Thiotepa | 1977 |